Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NHKC-1 vs valsartan in primary hypertension
CTR20230973Phase 3Completed
- Sponsor
- Sunshine Novo
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan + levamlodipine in essential hypertension, sponsored by Sunshine Novo. Started Apr 2023; status: completed.
02
Drugs
valsartan + levamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20230973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230973.